tiprankstipranks
Trending News
More News >
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
India Market

Bal Pharma Limited (BALPHARMA) Income Statement

Compare
0 Followers

Bal Pharma Limited Income Statement

Last quarter (Q2 2025), Bal Pharma Limited's total revenue was ₹736.94M, a decrease of -20.37% from the same quarter last year. In Q2, Bal Pharma Limited's net income was ₹10.42M. See Bal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 3.03B₹ 3.39B₹ 3.04B₹ 2.81B₹ 2.51B
Gross Profit
₹ 730.18M₹ 770.20M₹ 1.31B₹ 1.11B₹ 993.03M
Operating Expenses
₹ 532.29M₹ 555.63M₹ 1.15B₹ 967.88M₹ 822.16M
Depreciation and Amortization
₹ 97.71M₹ 100.71M₹ 91.28M₹ 90.40M₹ 95.21M
EBITDA
₹ 317.63M₹ 320.23M₹ 245.00M₹ 287.64M₹ 257.82M
Operating Income
₹ 197.89M₹ 214.57M₹ 169.35M₹ 144.36M₹ 170.88M
Other Income/Expenses
₹ -146.51M₹ -124.10M₹ -129.75M₹ -488.46M₹ -99.62M
Pretax Income
₹ 51.38M₹ 90.47M₹ 47.48M₹ 91.83M₹ 41.03M
Net Income
₹ 72.15M₹ 73.92M₹ 25.72M₹ 56.12M₹ 47.42M
Per Share Metrics
Basic EPS
₹ 4.56₹ 4.94₹ 1.64₹ 3.79₹ 3.34
Diluted EPS
₹ 4.56₹ 4.68₹ 1.64₹ 3.71₹ 3.34
Weighted Average Shares Outstanding
0.00 14.96M 15.69M 14.82M 14.20M
Weighted Average Shares Outstanding (Diluted)
0.00 15.80M 15.69M 15.14M 14.20M
Currency in INR

Bal Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis